The head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital discussed positive clinical trial findings for a dual-target neuroprotectant in patients with acute ischemic stroke presented at ISC 2026. [WATCH TIME: 3 minutes]
Shuya Li, MD
Advertisement
Director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.
Articles by Shuya Li, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Advanced Therapy with Apomorphine Pump in Parkinson’s Disease
2
SKY-0515 Demonstrates Sustained Mutant Huntingtin Lowering in Latest Phase 1/2 Study Update
3
Inside the Development of ISSCR’s New Parkinson Disease Stem Cell Program
4
Managing OFF Time in Parkinson’s Disease
5